Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BNTC Benitec Biopharma

Pre-Market Trading 11-26 08:58:09 EST

10.15

-0.34

-3.24%

High10.60	Low10.12	Vol23.63K
Open10.48	D1 Closing10.49	Amplitude4.57%
Mkt Cap235.65M	Tradable Cap108.42M	Total Shares23.22M
T/O243.93K	T/O Rate0.22%	Tradable Shares10.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BNTC","market":"US","secType":"STK","nameCN":"Benitec Biopharma","latestPrice":10.15,"timestamp":1732568400000,"preClose":10.49,"halted":0,"volume":23633,"delay":0,"floatShares":10681600,"shares":23216425,"eps":-3.380809,"marketStatus":"Pre-Market Trading","change":-0.34,"latestTime":"11-26 08:58:09 EST","open":10.48,"high":10.5999,"low":10.12,"amount":243934.61266,"amplitude":0.045748,"askPrice":11.66,"askSize":100,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.380809,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1732631400000},"marketStatusCode":1,"adr":1,"adrRate":200,"listingDate":1439870400000,"exchange":"NASDAQ","adjPreClose":10.15,"postHourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.15,"latestTime":"17:32 EST","volume":6,"amount":60.15,"timestamp":1732573968722},"volumeRatio":0.5981982439451876,"impliedVol":4.2015,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BNTC/wiki","defaultTab":"wiki","newsList":[{"id":"2486071672","title":"Benitec Biopharma to Participate in Upcoming Investor Conferences in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2486071672","media":"GlobeNewswire","labels":["Important Conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486071672?lang=en_us&edition=fundamental","pubTime":"2024-11-26 20:00","pubTimestamp":1732622400,"startTime":"0","endTime":"0","summary":"HAYWARD, Calif., Nov.  26, 2024  (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/26/2987335/0/en/Benitec-Biopharma-to-Participate-in-Upcoming-Investor-Conferences-in-December.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Important Conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139","WRD"],"gpt_icon":0},{"id":"2484121998","title":"Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484121998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484121998?lang=en_us&edition=fundamental","pubTime":"2024-11-19 15:30","pubTimestamp":1732001429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Benitec Biopharma (BNTC – Research Report), Bluebird...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-bluebird-bio-blue-and-ac-immune-sa-aciu?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-bluebird-bio-blue-and-ac-immune-sa-aciu?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4139","BK4135","BK4556","BLUE","ACIU","AC","BNTC","BK4578","BK4137"],"gpt_icon":0},{"id":"2484069758","title":"Analysts Are Bullish on These Healthcare Stocks: Steris (STE), Benitec Biopharma (BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484069758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484069758?lang=en_us&edition=fundamental","pubTime":"2024-11-18 13:30","pubTimestamp":1731907819,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Steris (STE – Research Report), Benitec Biopharma (B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-steris-ste-benitec-biopharma-bntc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-steris-ste-benitec-biopharma-bntc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BNTC","STE","BK4588","LU1892829315.USD","BK4585","BK4082","BK4139","BK4137"],"gpt_icon":0},{"id":"2483713013","title":"Benitec Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483713013","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483713013?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:06","pubTimestamp":1731679592,"startTime":"0","endTime":"0","summary":"* Benitec Biopharma Inc    reported a quarterly adjusted loss of 48 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-2.76.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Benitec Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"gpt_icon":0},{"id":"2483356929","title":"Benitec Biopharma Q1 2025 GAAP EPS $(0.48) Beats $(0.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483356929","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483356929?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:19","pubTimestamp":1731622790,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41993653/benitec-biopharma-q1-2025-gaap-eps-0-48-beats-0-55-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Benitec Biopharma Q1 2025 GAAP EPS $(0.48) Beats $(0.55) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"gpt_icon":0},{"id":"2483989355","title":"Benitec Biopharma Awards Bonuses to Key Executives","url":"https://stock-news.laohu8.com/highlight/detail?id=2483989355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483989355?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:01","pubTimestamp":1731621715,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Benitec Biopharma ( ($BNTC) ). Benitec Biopharma Inc. has awarded discretionary bonuses to key executives for t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-awards-bonuses-to-key-executives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-awards-bonuses-to-key-executives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2483358314","title":"Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358314?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA5KXVH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BNTC"],"gpt_icon":0},{"id":"2483358345","title":"Benitec Biopharma Q1 Operating Income USD -5.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358345?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLX243682:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BNTC"],"gpt_icon":0},{"id":"2483358138","title":"Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358138","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358138?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619800,"startTime":"0","endTime":"0","summary":"-Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject Treated with the Low-Dose of BB-301 in the Phase 1b/2a Clini","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981651/0/en/Benitec-Biopharma-Releases-First-Quarter-2025-Financial-Results-and-Provides-Operational-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","BNTC","BK4585","BK4097","BK4588","TPR","LU1267930227.SGD","BK4202","BK4516","LU0052756011.USD","LU0128525689.USD","LU0320765489.SGD","BK4547","LU0310800965.SGD","LU0070302665.USD","BK4139"],"gpt_icon":1},{"id":"2482484648","title":"Benitec Biopharma Inc  expected to post a loss of 55 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482484648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482484648?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:48","pubTimestamp":1731084500,"startTime":"0","endTime":"0","summary":"Benitec Biopharma Inc  expected to post a loss of55cents a share - Earnings Preview Benitec Biopharma Inc BNTC.OQ BNTC.O is expected to show no change in quarterly revenue when it reports  results on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF2WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"gpt_icon":0},{"id":"2481220901","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2481220901","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481220901?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:00","pubTimestamp":1731063600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Amer. Axle & Mnfg                                3Q      (.05)  8:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIRS","COCP","ATOS","ACLX","BNTC","XAIR","OCS","ATAI","NPWR","PAGP","CLMT","HUMA","INTS","APGE","MSGE","VINC","FBRX","TSBX","ATSG","GTN","FLR","GSL","SGMT","AGO","ZETA","XERS","RBA","AHR","HLLY","VRDN","ANIP","ABOS","ZURA","GCMG","KT","AMRX","AMTX","MASS","NRXP","TSVT","AVTE","GATO","PAA","LAZR","SBS","WMS","BLMN","ALT","BAX","PARA"],"gpt_icon":1},{"id":"2480300632","title":"Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2480300632","media":"GlobeNewswire","labels":["Important Conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480300632?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:00","pubTimestamp":1730725200,"startTime":"0","endTime":"0","summary":"HAYWARD, Calif., Nov. 04, 2024  -- Benitec Biopharma Inc.  , a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference  platform, today announces CEO Jerel A. Banks, M.D., Ph.D. will be participating in the Guggenheim Securities Healthcare Conference, taking place in Boston from November 11-13, 2024.Date: November 11, 2024Time: 2:30 PMFormat: Fireside Chat & 1x1 Meetings. The Benitec presentation will also be available via live webcasthere.Please contact your Guggenheim representative to schedule a 1x1 meeting with Benitec management.About Benitec Biopharma Inc.Benitec Biopharma Inc.  is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary “Silence and Replace” DNA-directed RNA interference platform combines RNA interference, or RNAi, with gene therapy to create medicines tha","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wGa4eMZPcYrmKWNEWoa9rw--~B/aD0yNTQ7dz04MDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6420004cb8cbc8cbf0c4b9dec039e88f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wGa4eMZPcYrmKWNEWoa9rw--~B/aD0yNTQ7dz04MDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6420004cb8cbc8cbf0c4b9dec039e88f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/benitec-biopharma-ceo-participate-guggenheim-130000053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Important Conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","BNTC","BK4139","HCSG"],"gpt_icon":1},{"id":"2480886983","title":"BRIEF-Benitec Biopharma files for mixed shelf of up to $125 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2480886983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480886983?lang=en_us&edition=fundamental","pubTime":"2024-11-02 06:13","pubTimestamp":1730499211,"startTime":"0","endTime":"0","summary":"Nov 1 (Reuters) - Benitec Biopharma Inc   :   * BENITEC BIOPHARMA INC FILES FOR MIXED SHELF OF UP TO  $125 MILLION - SEC FILINGSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UP","BNTC","BK4008"],"gpt_icon":0},{"id":"2476285196","title":"Benitec Biopharma (BNTC) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2476285196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476285196?lang=en_us&edition=fundamental","pubTime":"2024-10-18 18:36","pubTimestamp":1729247795,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Benitec Biopharma (BNTC – Research Report), with a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/benitec-biopharma-bntc-receives-a-buy-from-piper-sandler-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/benitec-biopharma-bntc-receives-a-buy-from-piper-sandler-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2476431256","title":"Benitec Biopharma: OPMD Program Continues To Advance With Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2476431256","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476431256?lang=en_us&edition=fundamental","pubTime":"2024-10-18 03:35","pubTimestamp":1729193710,"startTime":"0","endTime":"0","summary":"Benitec Biopharma Inc.'s BB-301 showed positive interim results in treating OPMD, allowing for higher dosing in 2025 and a potential late-stage trial in 2026.BB-301 demonstrated significant improvements in swallowing function and reduced pharyngeal residue, with no serious adverse events reported in the phase 1b/2a study.Financially, Benitec Biopharma is well-positioned with $50.9 million in cash, sufficient to fund operations through 2025, thanks to a $40 million PIPE financing.Risks include uncertain efficacy and safety of higher BB-301 doses, and regulatory hurdles for advancing to pivotal phase 3 trials.   Solskin Benitec Biopharma Inc.  recently reported positive results from its phase 1b/2a clinical study using BB-301 for the treatment of patients with Oculopharyngeal Muscular Dystrophy [OPMD]. It reported these positive interim results at two time points during 2024 showing initial proof-of-concept that this gene therapy works in being able to treat these patients with this rare","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168166158/image_168166158.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168166158/image_168166158.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4727454-benitec-biopharma-opmd-program-continues-to-advance-with-catalysts","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2476692064","title":"Benitec started at outperform by Oppenheimer on gene therapy potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2476692064","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476692064?lang=en_us&edition=fundamental","pubTime":"2024-10-17 03:51","pubTimestamp":1729108281,"startTime":"0","endTime":"0","summary":"peterschreiber.media  Oppenheimer started coverage of Benitec Biopharma (NASDAQ:BNTC) at outperform, citing its gene therapy candidate BB-301 for the treatment of ocular pharyngeal muscular dystrophy,","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182811515/image_1182811515.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182811515/image_1182811515.jpg?io=getty-c-w750"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4167071-benitec-started-at-outperform-by-oppenheimer-on-gene-therapy-potential","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["OPY","BNTC"],"gpt_icon":0},{"id":"2475960018","title":"Oppenheimer Initiates Coverage on Benitec Biopharma With Outperform Rating, $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2475960018","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475960018?lang=en_us&edition=fundamental","pubTime":"2024-10-16 20:13","pubTimestamp":1729080824,"startTime":"0","endTime":"0","summary":"Price: 10.21, Change: +0.40, Percent Change: +4.08","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTC","OPY"],"gpt_icon":0},{"id":"2475960573","title":"Benitec Biopharma Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2475960573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475960573?lang=en_us&edition=fundamental","pubTime":"2024-10-16 20:07","pubTimestamp":1729080446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nFWN3LS15O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2475955833","title":"Benitec Biopharma Initiated at Outperform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2475955833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475955833?lang=en_us&edition=fundamental","pubTime":"2024-10-16 17:22","pubTimestamp":1729070520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 16, 2024 05:22 ET (09:22 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPY","BNTC"],"gpt_icon":0},{"id":"2475369859","title":"Benitec Biopharma initiated with an Outperform at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2475369859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475369859?lang=en_us&edition=fundamental","pubTime":"2024-10-16 04:11","pubTimestamp":1729023112,"startTime":"0","endTime":"0","summary":"Oppenheimer initiated coverage of Benitec Biopharma with an Outperform rating and $35 price target Benitec’s proprietary “silence and replace” DNA-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-initiated-with-an-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-initiated-with-an-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC","OPY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.benitec.com","stockEarnings":[{"period":"1week","weight":0.0595},{"period":"1month","weight":-0.0764},{"period":"3month","weight":0.0844},{"period":"6month","weight":0.3444},{"period":"1year","weight":2.1719},{"period":"ytd","weight":2.1424}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.06227},{"month":2,"riseRate":0.555556,"avgChangeRate":0.110444},{"month":3,"riseRate":0.777778,"avgChangeRate":0.056589},{"month":4,"riseRate":0.333333,"avgChangeRate":0.02399},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.070564},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.119694},{"month":7,"riseRate":0.555556,"avgChangeRate":0.075553},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.028649},{"month":9,"riseRate":0.2,"avgChangeRate":-0.125403},{"month":10,"riseRate":0.6,"avgChangeRate":-0.045727},{"month":11,"riseRate":0.3,"avgChangeRate":-0.061275},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.071947}],"exchange":"NASDAQ","name":"Benitec Biopharma","nameEN":"Benitec Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Benitec Biopharma(BNTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Benitec Biopharma,BNTC,Benitec Biopharma股票,Benitec Biopharma股票老虎,Benitec Biopharma股票老虎国际,Benitec Biopharma行情,Benitec Biopharma股票行情,Benitec Biopharma股价,Benitec Biopharma股市,Benitec Biopharma股票价格,Benitec Biopharma股票交易,Benitec Biopharma股票购买,Benitec Biopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Benitec Biopharma(BNTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction